Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, control... von Eng, Cathy, Kim, Tae Won, Bendell, Johanna, Argilés, Guillem, Tebbutt, Niall C, Di Bartolomeo, Maria, Falcone, Alfredo, Fakih, Marwan, Kozloff, Mark, Segal, Neil H, Sobrero, Alberto, Yan, Yibing, Chang, Ilsung, Uyei, Anne, Roberts, Louise, Ciardiello, Fortunato, Ahn, JB, Asselah, J, Badarinath, S, Baijal, S, Begbie, S, Berry, S, Canon, JL, Carbone, RG, Cervantes, A, Cha, YJ, Chang, K, Chaudhry, A, Chmielowska, E, Cho, SH, Chu, D, Couture, F, Cultrera, J, Cunningham, D, Van Cutsem, E, Cuyle, PJ, Davies, J, Dowden, S, Dvorkin, M, Ganju, V, Garcia, RV, Kerr, R, Kim, TY, King, K, Kortmansky, J, Kozloff, M, Lam, KO, Lee, J, Lee, AS, Lesperance, B, Luppi, G, Ma, B, Maiello, E, Mandanas, R, Marshall, J, Marx, G, Mullamitha, S, Nechaeva, M, Park, JO, Pavlakis, N, Ponce, CG, Potemski, P, Raouf, S, Reeves, J, Segal, N, Siena, S, Smolin, A, Streb, JO, Strickland, A, Szutowicz-Zielinska, E, Tabernero, JM, Tan, B, Valera, JS, Van den Eynde, M, Vergauwe, P, Vickers, M, Womack, M, Wroblewska, M, Young, R

Volltext

Magneto-excitons in Cu2O: theoretical model from weak to high magnetic fields von Zieli ska-Raczy ska, Sylwia, Fishman, Dmitry A, Faugeras, Clément, Potemski, Marek M P, van Loosdrecht, Paul H M, Karpi ski, Karol, Czajkowski, Gerard, Ziemkiewicz, David

Volltext

Functionalized nanoparticles as tools in anti-cancer treatment von Kędzierska, M., Tyliszczak, B., Drabczyk, A., Kudłacik–Kramarczyk, S., Potemski, P.

Volltext

Polymer hydrogels as innovative carriers for anticancer therapy von Kędzierska, M., Drabczyk, A., Kudłacik–Kramarczyk, S., Potemski, P., Tyliszczak, B.

Volltext

Integrin alpha 3 beta 1-CD151 complex regulates dimerization of ErbB2 via RhoA von Novitskaya, V, Romanska, H, Kordek, R, Potemski, P, Kusinska, R, Parsons, M, Odintsova, E, Berditchevski, F

Volltext

Prognostic and predictive value of phosphorylated HER2, HER3 and PTEN expression in patients with HER2-positive breast cancer treated with trastuzumab von Debska-Szmich, S., Kusinska, R., Krakowska, M., Czyzykowski, R., Czernek, U., Zadrozna, A., Potemski, P.

Volltext

Integrin α3β1–CD151 complex regulates dimerization of ErbB2 via RhoA von Novitskaya, V, Romanska, H, Kordek, R, Potemski, P, Kusińska, R, Parsons, M, Odintsova, E, Berditchevski, F

Volltext

P-032A complete blood count as a prognostic marker in patients with metastatic colorectal cancer (mCRC) von Krakowska, M, Debska-Szmich, S, Czernek, U, Czyzykowski, R, Potemski, P

Volltext

WWOX—the FRA16D cancer gene: Expression correlation with breast cancer progression and prognosis von Płuciennik, E., Kusińska, R., Potemski, P., Kubiak, R., Kordek, R., Bednarek, A.K.

Volltext

Loss of CD151/Tspan24 from the complex with integrin α3β1 in invasive front of the tumour is a negative predictor of disease-free survival in oral squamous cell carcinoma von Romanska, H.M, Potemski, P, Collins, S.I, Williams, H, Parmar, S, Berditchevski, F

Volltext

86P Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase III TOPAZ-1 st... von He, A.R., Valle, J.W., Lee, C-K., Ikeda, M., Potemski, P., Morizane, C., Cundom, J.E., Tougeron, D., Dayyani, F., Rokutanda, N., Xiong, J., Cohen, G., Oh, D-Y.

Volltext

O-1 Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 stud... von He, A., Valle, J., Lee, C., Ikeda, M., Potemski, P., Morizane, C., Cundom, J., Tougeron, D., Dayyani, F., Rokutanda, N., Xiong, J., Cohen, G., Oh, D.

Volltext

Early increase of high-sensitivity cardiac troponin predicts mortality in cancer patients undergoing chemotherapy von Nowakowska, M A, Chrzanowski, L, Miskowiec, D, Wdowiak-Okrojek, K, Wejner-Mik, P, Lipiec, P, Krakowska, M, Potemski, P, Plonska-Gosciniak, E, Kasprzak, J D

Volltext

Evaluation of oestrogen receptor expression in breast cancer by quantification of mRNA von Potemski, P, Pluciennik, E, Bednarek, A K, Kusinska, R, Kubiak, R, Kordek, R

Volltext

P-334Functionalized nanoparticles as tools in anti-cancer treatment von Kędzierska, M, Tyliszczak, B, Drabczyk, A, Kudłacik–Kramarczyk, S, Potemski, P

Volltext

Scanning tunneling spectroscopy of van der Waals graphene/semiconductor interfaces: absence of Fermi level pinning von Le Quang, T, Cherkez, V, Nogajewski, K, Potemski, M, Dau, M T, Jamet, M, Mallet, P, Veuillen, J-Y

Volltext

54PPrognostic and predictive value of phosphorylated HER2, HER3 and PTEN expression in patients with HER2-positive breast cancer treated with trastuzumab von Debska-Szmich, S, Kusinska, R, Krakowska, M, Czyzykowski, R, Czernek, U, Zadrozna, A, Potemski, P

Volltext

P-027Polymer hydrogels as innovative carriers for anticancer therapy von Kędzierska, M, Drabczyk, A, Kudłacik-Kramarczyk, S, Potemski, P, Tyliszczak, B

Volltext

P-032 A complete blood count as a prognostic marker in patients with metastatic colorectal cancer (mCRC) von Krakowska, M., Debska-Szmich, S., Czernek, U., Czyzykowski, R., Potemski, P.

Volltext

Skin toxicity in a patient with ovarian cancer treated with pegylated liposomal doxorubicin: A case report and review of the literature von Kubicka-Wołkowska, Joanna, Kędzierska, Magdalena, Lisik-Habib, Maja, Potemski, Piotr

Volltext